IL17A and neoplasm: We then detected the IL-17A+cells in their tumor tissues and found that the counts of IL-17A+cells in two patients were less than 10/HPF, including one patient with PR and one patient with stable disease (SD, tumor reduction of 16% relative to baseline) (figure 7H).